Skip to main content
. 2012 Jun 5;7:2473–2481. doi: 10.2147/IJN.S30500

Table 4.

Role of ABCB1 knockdown in enhancing cytotoxic effects of anti-cancer drugs at 10 pM to 1 nM (doxorubicin and paclitaxel) and 100 pM to 10 nM (cisplatin)

siRNA % enhancement of chemosensitivity


ABCB1 Doxorubicin Paclitaxel Cisplatin



10 pM 100 pM 1 nM 10 pM 100 pM 1 nM 100 pM 1 nM 10 nM
1 nM 30% 18% 18% 27% 23% 26% 4% 10% 14%

Abbreviation: siRNA, small interfering RNA.